Results 191 to 200 of about 9,251,777 (236)

[CA 15-3 and breast cancer].

La Revue de medecine interne, 1995
The precise clinical value of CA 15-3 antigen has yet to be determined. With no role in screening for early breast cancer and, even if CA 15-3 seems to be correlated with bulky initial tumor burden, it appears to have no independent prognostic value. The clinical interest of CA 15-3 remains the early detection of the first recurrence.
E, Antoine, L, Kayitalire, M, Spielmann
openaire   +1 more source

Carbohydrate Antigen CA 15-3

1995
CA 15-3 is a 290 000 Da cell surface antigen defined by a heterologous monoclonal antibody system employing two distinct antibodies. The first antibody — 115D8 — is specific for a human milkfat globule membrane antigen, whilst the second — DF3 — was derived by immunization with a membrane enriched fraction from human breast carcinoma.
openaire   +1 more source

Chemotherapy-induced pneumonitis associated with transient CA 15-3 elevation

Journal of Oncology Pharmacy Practice, 2020
Introduction Development of hypersensitivity pneumonitis has been reported in association with combination chemotherapy consisting of gemcitabine and paclitaxel. However, diagnosis of this condition is based on computed tomography imaging and correlative bronchoalveolar findings on bronchoscopy.
openaire   +2 more sources

Informations réactifs: Marqueurs tumoraux: CA 19-9, CA 125, CA 15-3, CA 50, CA 72-4

Immuno-analyse & Biologie Spécialisée, 1996
NDRL. Cette rubrique a pour but d'informer les utilisateurs de l'immunoanalyse des divers reactifs commerciaux disponibles en France. II ne s'agit pas du releve exhaustif des caracteristiques, tel que les fabricants ou les distributeurs sont en mesure de le fournir aux utilisateurs, mais de quelques informations permettant une classification (signal ...
openaire   +1 more source

CA15-3 und Mammakarzinom

Archives of Gynecology and Obstetrics, 1989
Beim primaren Mammakarzinom betragt die Sensitivitat des CEA lediglich 12%, die des Ca15-3 18% und die des TPA 37%. Von den Untersuchten Markern entspricht TPA (Grenze>85 U/l) am ehesten den Erwartungen eines Tumormarkers beim Mammakarzinom. Ca 15-3 ist geringfugig besser als CEA bei niedrigen Erfassungsraten (12% bzw. 18%).
W. Krieg, U. Lorenz, T. Scheiber
openaire   +1 more source

Aussagekraft der Tumormarker CA 125, CA 19-9, CA 15-3 und CEA bei Endometriose

Geburtshilfe und Frauenheilkunde, 1991
CA 125, CA 19-9, CA 15-3 and CEA were measured in 42 patients with histologically verified endometriosis, who had been treated for six months by the LHRH-analogue buserelin (900 mcg/d intranasally). Before therapy, for all of the markers tested the sensitivity was as follows: CA 125 49%, CA 19-9 19%, CA 15-3 19% and CEA 0%.
U. Cirkel, H. Ochs, B. Latussek, H. Schneider   +3 more
openaire   +1 more source

CA 15-3

Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2017
D. Brüggmann, D. Ohlendorf, D. Klingelhöfer, E. Wanke, G. M. Oremek, D. Quarcoo   +5 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

CA 15-3

Drugs of the Future, 1987
openaire   +1 more source

Malign plevral efüzyonlarda CEA, CA 19-9, CA 125 ve CA 15-3 düzeyleri

2020
51
openaire   +1 more source